In a multicentre, examiner-blind, clinical and neurophysiological study lasting 4 months, 120 hands from 82 patients with mild-to-moderate carpal tunnel syndrome were examined at baseline and 10, 60, and 120 days after treatment with 500 mg of acetyl-l-carnitine twice daily for 10 days intramuscularly followed by oral administration at 500 mg twice daily for 4 months
Ideal for those experiencing arthritis, sports injuries, or chronic pain, peptide therapy works at the root level to help your body repair and protect itself from within
KLOW is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use
A non-inferiority margin of 0.3% is generally accepted, although it is subject to changes based on the clinical context
doi: 10.1016/S0140-6736(21)01919-X 72 De BlockCEMDirinckEVerhaegenAVan GaalLF